Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,824
Closed -$19.9M 26
2025
Q4
$19.9M Sell
60,824
-9,000
-13% -$2.85M 2.08% 12
2025
Q3
$19.7M Hold
69,824
2.62% 12
2025
Q2
$19.5M Sell
69,824
-193
-0.3% -$54.7K 1.84% 16
2025
Q1
$21.8M Sell
70,017
-21,593
-24% -$6.38M 2.41% 14
2024
Q4
$23.9M Buy
91,610
+51,992
+131% +$15.4M 2.22% 14
2024
Q3
$12.8M Sell
39,618
-36,094
-48% -$11.8M 0.71% 39
2024
Q2
$23.7M Buy
75,712
+26,553
+54% +$7.8M 0.48% 40
2024
Q1
$14M Buy
49,159
+47,820
+3,571% +$14M 0.86% 27
2023
Q4
$386K Sell
1,339
-26,000
-95% -$7.08M 0.02% 83
2023
Q3
$7.35M Sell
27,339
-24,502
-47% -$6.11M 0.44% 45
2023
Q2
$11.5M Buy
51,841
+32,213
+164% +$7.47M 0.6% 35
2023
Q1
$4.75M Buy
19,628
+18,544
+1,711% +$4.55M 0.26% 45
2022
Q4
$285K Hold
1,084
0.01% 98
2022
Q3
$244K Hold
1,084
0.01% 93
2022
Q2
$264K Buy
+1,084
New +$266K 0.01% 98
2022
Q1
Sell
-5,494
Closed -$1.24M 103
2021
Q4
$1.24M Buy
+5,494
New +$1.16M 0.02% 112

Other funds holding AMGN

MBB Public Markets's AMGN Position: Q1 2026 in Review

MBB Public Markets sold out of Amgen (AMGN) in Q1 2026, closing a stake of 60,824 shares — an estimated $19.9M sold.

MBB Public Markets first reported a position in AMGN in Q4 2021 and held it in 16 quarters. The position peaked at $23.9M in Q4 2024. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • MBB Public Markets reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • MBB Public Markets sold 60,824 Amgen shares in Q1 2026, an estimated $19.9M.
  • MBB Public Markets first reported a position in Amgen in Q4 2021 and held it in 16 quarters.
  • MBB Public Markets's Amgen position peaked at $23.9M in Q4 2024.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on MBB Public Markets's 13F filing for Q1 2026, filed 15 May 2026.